vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and Riley Exploration Permian, Inc. (REPX). Click either name above to swap in a different company.

Riley Exploration Permian, Inc. is the larger business by last-quarter revenue ($97.3M vs $90.3M, roughly 1.1× Evolus, Inc.). On growth, Evolus, Inc. posted the faster year-over-year revenue change (14.4% vs -5.3%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (23.4% CAGR vs -1.2%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

Riley Exploration Permian, Inc. is an independent energy company focused on exploration, development, and production of crude oil, natural gas, and natural gas liquids primarily in the US Permian Basin spanning Texas and New Mexico. It prioritizes cost-efficient onshore reserve development to supply reliable energy products to North American markets.

EOLS vs REPX — Head-to-Head

Bigger by revenue
REPX
REPX
1.1× larger
REPX
$97.3M
$90.3M
EOLS
Growing faster (revenue YoY)
EOLS
EOLS
+19.7% gap
EOLS
14.4%
-5.3%
REPX
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
23.4%
-1.2%
REPX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EOLS
EOLS
REPX
REPX
Revenue
$90.3M
$97.3M
Net Profit
$130.0K
Gross Margin
65.7%
Operating Margin
4.7%
26.9%
Net Margin
0.1%
Revenue YoY
14.4%
-5.3%
Net Profit YoY
101.9%
EPS (diluted)
$0.01
$4.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
REPX
REPX
Q4 25
$90.3M
$97.3M
Q3 25
$69.0M
$106.9M
Q2 25
$69.4M
$85.4M
Q1 25
$68.5M
$102.5M
Q4 24
$78.9M
$102.7M
Q3 24
$61.1M
$102.3M
Q2 24
$66.9M
$105.4M
Q1 24
$59.3M
$99.7M
Net Profit
EOLS
EOLS
REPX
REPX
Q4 25
$130.0K
Q3 25
$-15.7M
$16.3M
Q2 25
$-17.1M
$30.5M
Q1 25
$-18.9M
$28.6M
Q4 24
$-6.8M
Q3 24
$-19.2M
$25.7M
Q2 24
$-11.3M
$33.5M
Q1 24
$-13.1M
$18.8M
Gross Margin
EOLS
EOLS
REPX
REPX
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Q1 24
68.3%
Operating Margin
EOLS
EOLS
REPX
REPX
Q4 25
4.7%
26.9%
Q3 25
-16.7%
27.0%
Q2 25
-14.7%
33.7%
Q1 25
-22.1%
48.3%
Q4 24
-2.9%
31.2%
Q3 24
-25.3%
17.1%
Q2 24
-11.5%
50.9%
Q1 24
-15.0%
50.7%
Net Margin
EOLS
EOLS
REPX
REPX
Q4 25
0.1%
Q3 25
-22.8%
15.3%
Q2 25
-24.7%
35.7%
Q1 25
-27.6%
27.9%
Q4 24
-8.6%
Q3 24
-31.4%
25.1%
Q2 24
-17.0%
31.8%
Q1 24
-22.1%
18.8%
EPS (diluted)
EOLS
EOLS
REPX
REPX
Q4 25
$0.01
$4.02
Q3 25
$-0.24
$0.77
Q2 25
$-0.27
$1.44
Q1 25
$-0.30
$1.36
Q4 24
$-0.11
$0.52
Q3 24
$-0.30
$1.21
Q2 24
$-0.18
$1.59
Q1 24
$-0.22
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
REPX
REPX
Cash + ST InvestmentsLiquidity on hand
$53.8M
Total DebtLower is stronger
$146.1M
$247.9M
Stockholders' EquityBook value
$-23.1M
$634.2M
Total Assets
$225.9M
$1.2B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
REPX
REPX
Q4 25
$53.8M
Q3 25
$43.5M
Q2 25
$61.7M
Q1 25
$67.9M
Q4 24
$87.0M
Q3 24
$85.0M
Q2 24
$93.7M
Q1 24
$97.0M
Total Debt
EOLS
EOLS
REPX
REPX
Q4 25
$146.1M
$247.9M
Q3 25
$367.0M
Q2 25
$275.2M
Q1 25
$121.8M
$249.3M
Q4 24
$121.5M
$269.5M
Q3 24
$121.2M
$288.6M
Q2 24
$120.9M
$322.7M
Q1 24
$120.6M
$341.8M
Stockholders' Equity
EOLS
EOLS
REPX
REPX
Q4 25
$-23.1M
$634.2M
Q3 25
$-28.8M
$566.5M
Q2 25
$-18.7M
$556.9M
Q1 25
$-6.6M
$532.4M
Q4 24
$5.5M
$510.6M
Q3 24
$5.9M
$507.4M
Q2 24
$19.3M
$489.0M
Q1 24
$18.4M
$434.6M
Total Assets
EOLS
EOLS
REPX
REPX
Q4 25
$225.9M
$1.2B
Q3 25
$219.0M
$1.2B
Q2 25
$228.8M
$1.0B
Q1 25
$213.4M
$994.9M
Q4 24
$232.6M
$993.5M
Q3 24
$229.6M
$997.9M
Q2 24
$233.8M
$1.0B
Q1 24
$226.2M
$956.4M
Debt / Equity
EOLS
EOLS
REPX
REPX
Q4 25
0.39×
Q3 25
0.65×
Q2 25
0.49×
Q1 25
0.47×
Q4 24
22.00×
0.53×
Q3 24
20.58×
0.57×
Q2 24
6.26×
0.66×
Q1 24
6.54×
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
REPX
REPX
Operating Cash FlowLast quarter
$12.8M
$64.9M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
12.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
98.67×
TTM Free Cash FlowTrailing 4 quarters
$-45.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
REPX
REPX
Q4 25
$12.8M
$64.9M
Q3 25
$-14.7M
$63.6M
Q2 25
$-24.8M
$33.6M
Q1 25
$-15.6M
$50.4M
Q4 24
$4.8M
$66.4M
Q3 24
$-5.7M
$72.1M
Q2 24
$-6.5M
$51.6M
Q1 24
$-10.6M
$56.1M
Free Cash Flow
EOLS
EOLS
REPX
REPX
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-6.0M
Q2 24
$-6.9M
Q1 24
$-10.9M
FCF Margin
EOLS
EOLS
REPX
REPX
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-9.9%
Q2 24
-10.4%
Q1 24
-18.3%
Capex Intensity
EOLS
EOLS
REPX
REPX
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.7%
Q1 24
0.4%
Cash Conversion
EOLS
EOLS
REPX
REPX
Q4 25
98.67×
Q3 25
3.90×
Q2 25
1.10×
Q1 25
1.76×
Q4 24
Q3 24
2.81×
Q2 24
1.54×
Q1 24
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons